Navigation Links
FDA Issues a Complete Response Letter for Lilly's Olanzapine LAI for Treatment of Schizophrenia in Adults
Date:1/7/2009

from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

P-LLY

This press release contains forward-looking statements about the safety and efficacy of olanzapine long acting injection (LAI) and reflects Lilly's current beliefs. However, as with any investigational pharmaceutical product, there are substantial risks and uncertainties in the process of research, development, regulatory milestones and commercialization. There is no guarantee that olanzapine LAI will be approved for the treatment of schizophrenia or that if approved, it will be commercially successful. For further discussion of these and other risks and uncertainties, see Lilly's filings with the United States Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.

1) Falkai P., Wobrock T., Lieberman J., Glenthoj B., Gattaz W.F., Moller H.J & Wfsbp Task Force On Treatment Guidelines For Schizophrenia. The World Journal of Biological Psychiatry, 2006; 7(1): 5/40

2) Kane J.M et al. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology, Volume 8, Number 1, 1 February 1998, pp. 55-66(12). p. 58.

3) Maxine X. Patel and Anthony S. David. Why aren't depot antipsychotics prescribed more often and what can be done about it? Advances in Psychiatric Treatment (2005) 11: 203-211.

4) American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition, 2000, pp. 298.

(Logo: http://www.
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. The First Annual Cervical Cancer/HPV Conference Tackles Controversial Vaccine Issues and Encourages Advocacy
2. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
3. European CHMP Issues Positive Opinion for ATRIPLA(R) (efavirenz 600 mg/ emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
4. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on CEL-SCI Corporation
6. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.
8. Lupus Under the Spotlight: U.S. Congress Shows Support for Womens Health Issues
9. European Unions CHMP Issues Positive Opinion on Sugammadex
10. Newly Published Study Shows OPKOs siRNA Bevasiranib Is Taken Up by Target Tissues in the Eye
11. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , Mexique, July 3, 2015 ... continue cible les épidémies que sont l,hypertension, le ... par l,intermédiaire de plateformes éducatives gratuites et d,une ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) , ... diabète en ligne , Prendre en charge ...
(Date:7/3/2015)... , July 3, 2015 ... with Broda Technologies Co., Ltd., operating in both the ... the company,s proprietary IntelliGel ® supramolecular hydrogel technology ... development and other ophthalmic therapies. The Broda technology offers ... solution is a free-forming liquid and with low concentrations ...
(Date:7/2/2015)... and VANCOUVER , July 2, 2015 ... EPI) announced today that its common shares have been approved ... under the symbol "EPIX". ESSA will begin trading ... its listing on the TSX Venture Exchange under the symbol ... the common shares on the NASDAQ, each of the Company,s ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4
... Diabecline® antibiotic ointment (SSPT® Tetracycline) received the Bronze Award ... Annual Edison Awards in New York City.  pharmaCline joined ... the New York Academy of Sciences, which hosted the ... Gala event acknowledged the hard work, innovation and commitment ...
...  Cohera Medical, Inc.®, a leading innovator and developer of ... of the first patient in a prospective, multicenter, randomized ... Surgical Adhesive in the United States.  Initiation of the ... of the lead product toward commercialization in the United ...
Cached Medicine Technology:Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product 2Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product 3First Patient Treated in U.S. Clinical Study of Cohera Medical's TissuGlu® Surgical Adhesive 2First Patient Treated in U.S. Clinical Study of Cohera Medical's TissuGlu® Surgical Adhesive 3
(Date:7/5/2015)... ... , ... City Sports, the Boston-based specialty sporting goods retailer, has renewed their ... triathletes this summer with ethos, the owner and operator of the Boston Triathlon. , ... p.m. at the North End Greenway. The event will help new triathletes prepare for ...
(Date:7/5/2015)... PA (PRWEB) , ... July 05, 2015 , ... ... of patented products, announces the Weed Master, a landscaping invention that effectively ... worth $75 billion US dollars," says Scott Cooper, CEO and Creative Director of ...
(Date:7/5/2015)... ... July 05, 2015 , ... Doctors at the Swedish ... IMRT/surgery combination may one day change the outlook for people with pleural mesothelioma. Surviving ... , Researchers report that five mesothelioma patients treated with 25Gy of radiation ...
(Date:7/4/2015)... ... July 04, 2015 , ... ... published the results of an annual member survey , detailing the most ... More recently, the group broke that raw data down into charts detailing demographic ...
(Date:7/4/2015)... York, NY (PRWEB) , ... July 04, 2015 , ... When a hacker gains access ... home front and at the office. On Wednesday, July 1st, the FTC issued a ... credentials as part of a verification process for a password reset instigated by the hacker. ...
Breaking Medicine News(10 mins):Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 2Health News:Sporting Goods Retailer City Sports Renews Partnership with Boston Triathlon 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 2Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 3Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 4Health News:8 Landscaping Tips That Can Save You Money Thanks To World Patent Marketing's Innovative Landscaping Invention 5Health News:New Mesothelioma Study Calls IMRT/Surgery Combo “Innovative and Promising”, According to Surviving Mesothelioma 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 2Health News:The ‘South Atlantic’ Frequently Chooses Tummy Tuck for Plastic Surgery, Jacksonville, FL, Doctor Notes 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 2Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 3Health News:New FTC Scam Alert Shows Latest Example of Social Engineering Dangers 4
... COLUMBIA, Mo. Despite billions of dollars spent on ... out of 33 developed countries for life expectancy at ... to pre-term birth or low birth weight-outcomes that have ... researcher says a key factor in addressing this issue ...
... world is a dazzling array of people, objects, sounds, smells ... at any moment. So our attention may automatically be snagged ... may deliberately focus on something that is important to us ... screaming hordes on the school playground. We also know that ...
... 7 (HealthDay News) -- Women who gain an excessive amount ... possible risk factor for childhood obesity, new research suggests. ... 25 to 35 pounds during pregnancy. Overweight women should keep ... should limit weight gain to 11 to 20 pounds. ...
... In what is believed to be the first published ... University School of Medicine (BUSM) believe female military service-members ... be as resilient to combat-related stress as men. These ... Abnormal Psychology . Though the literature suggests ...
... people out of the criminal justice system and into mental ... research from Queen Mary, University of London. In a study ... , researchers estimate that there are over 8,000 prisoners with ... If transferred to hospital, treatment for these patients would have ...
... fellow in cardiothoracic surgery research at Rhode Island Hospital, ... Surgery Foundation for Research and Education (TSFRE) to support ... Model of Chronic Cardiac Ischemia." TSFRE awarded just two ... years. TSFRE fellowships are designed to provide salary ...
Cached Medicine News:Health News:Health care providers need training to recognize signs of domestic violence, says nursing expert 2Health News:Your attention please: 'Rewarding' objects can't be ignored 2Health News:Your attention please: 'Rewarding' objects can't be ignored 3Health News:Too Much Weight Gain in Pregnancy Linked to Chubby Babies 2Health News:First of its kind study conducted by BUSM finds women as resilient to combat stress as men 2Health News:Rhode Island Hospital fellow receives funding to support research in myocardial perfusion 2
The K-ASSAY Rheumatoid Factor Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifying...
... The K-ASSAY Microalbumin Urine Controls ... to use liquid requiring no ... prepared from human urine, fortified ... albumin and creatinine. Preservatives including ...
... Liquid Lipid Control is intended for use ... test sample of known concentration for monitoring ... K-ASSAY Liquid Lipid Control with patient serum ... listed constituents. The user can compare observations ...
The K-ASSAY ITA Lyophilized Multi-Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assays for the li...
Medicine Products: